The 2019 novel coronavirus (2019-nCoV), officially named as COVID-19 pandemic by the WHO,...
Lancaster University reports positive data for HIV drugs in Covid-19
A statistician at Lancaster University in the UK has revealed positive results from a randomised clinical trial conducted in China to assess HIV drugs lopinavir and ritonavir for alleviating Covid-19 symptoms.
Inovio commences Phase I trial of DNA vaccine for Covid-19
Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application of its DNA vaccine candidate INO-4800 against Covid-19.
Penn researchers assess hydroxychloroquine for Covid-19
Researchers at the University of Pennsylvania’s Perelman School of Medicine have initiated a clinical trial to assess the use of anti-malarial drug hydroxychloroquine for the treatment of Covid-19.
Izana starts compassionate use study of potential Covid-19 drug
UK-based Izana Bioscience has launched a compassionate use study of namilumab (IZN-101) in patients with rapidly worsening Covid-19 in Bergamo and Milan, Italy.
Large-scale trial for coronavirus drugs launches in UK
The UK Government has announced that a large-scale randomised trial has been launched to assess potential treatments for Covid-19 (coronavirus).
Apeiron Biologics gets regulatory approval for Phase II Covid-19 trial
Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct a Phase II clinical trial of APN01 for the treatment of Covid-19.
Coronavirus outbreak: The countries affected
The 2019 novel coronavirus (2019-nCoV), officially named as COVID-19 pandemic by the WHO, has spread to more than 180 countries including China. Confirmed novel coronavirus cases increased ten-fold in less than a month, from 100,000 in the first week of March to more than one million on 02 April, while more than 52,000 deaths have been reported across the world. Europe has become the new epicentre of coronavirus. More than 90% of the global COVID-19 cases are currently outside China.
DCRI to trial hydroxychloroquine to prevent Covid-19
Duke Clinical Research Institute (DCRI) is set to conduct a randomised clinical trial of hydroxychloroquine to prevent Covid-19 in healthcare workers at risk of infection.